Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-09

Clinical Trial Update: Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism [NA]

View source ↗

Summary

A clinical trial compares superselective adrenal arterial embolization to oral spironolactone for idiopathic hyperaldosteronism. The study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Idiopathic Hyperaldosteronism, Hyperaldosteronism | NA | Status: RECRUITING